Australian entrepreneur, Lauren Barber, turned her nursing background into the role of an inventor and launched a medical device into the Australian healthcare industry.
Lauren began her career as a nurse at the Sydney Adventist Hospital and later moved into cosmetic dermatology, leading her to start her own company. Her journey as an entrepreneur has been challenging, but she has learned skills in resilience and crisis management. She still works as a nurse for 1-2 days a week to maintain her clinical skills. Her inspiration for this career path stems from a personal experience with a needle stick injury that led her to explore the relationship between needle-phobia and a person’s health.
NeedleCalm has now launched a new, world-leading medical device in Australia to improve vaccination rates and calm the nerves of the approximately six million Australians who fear injections. The Class 1 medical device, which recently received approval from the TGA, works by using a technique referred to as “closing the gate” between the needle injection site and pain receptors in the brain.
“Our technology is a game-changer and can be used in an estimated 76 million needle procedures in Australia each year. It’s easy to dismiss needle phobias, but they affect approximately 25% of Australians, while a local study found one in five patients with a fear of needles reported avoiding healthcare.”, says Lauren.
And today in Adelaide at the Australian College of Nursing’s National Nursing Forum, Lauren Barber was awarded the winner of the Health Minister’s Award for Nursing Trailblazers. The award acknowledges nurse-led innovations and models of care which significantly improve health outcomes for the Australian community through evidence-based processes.
With the support of her family and over 10 mentors who specialise in various areas, Lauren has overcome struggles in finance and fundraising. She has learned from her mistakes and now seeks advice from multiple sources before making a decision. In this reflection segment with Australian Health Journal, Lauren talks about the challenges of bringing a medical device to market, not just in company formation, regulatory approvals but also in selling to the health care procurement departments in hospitals.
No journey is linear for an entrepreneur, but Lauren has travelled considerable distance from a nursing student to a successful entrepreneur illustration her determination and passion to help those with needle phobias. Lauren’s work with NeedleCalm is making a positive impact in the healthcare industry and improving the experiences of patients and clinicians alike.
Adapted from Charles Sturt article “Lauren launches world-leading medical device to improve healthcare access”
You Might also like
-
Nurse led micro-suction earwax removal service continues success
At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.
-
Improving access to osteopathic services and integrated care models
The Chief Executive Officer of Osteopathy Australia, Antony Nicholas spoke with Australian Health Journal about:
– Involvement in the Strengthening Medicare Task Force
– The unique skills osteopaths have that can address the chronic disease burden
– Current workforce issues around osteopaths and if enough are coming through via student placements
– How uploading data to My Health Record by osteopaths could assist team-based care of patients
– How the value of osteopaths in Residential Aged Care Facilities (RACFs) could be better understood and better access for residents
– The recommendations around aged care access to allied health services, including osteopathy
– The recommendations around consumer access to osteopaths and GP referrals
– Other osteopathy recommendations in the upcoming Federal BudgetIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.